Effect of concanavalin A on immunologic abnormalities of New Zealand (NZB/W) mice

M. Eric Gershwin, A. D. Steinberg

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

The administration of concanavalin A (con A) to young New Zealand (NZB/W) mice has been found previously to render them tolerant to bovine γ globulin. The corresponding mechanism is unknown but is consistent with other observations that con A is capable of activating a suppressor T cell population. This possibility was further explored by giving New Zealand mice con A from 1 mth until 11 mth of age and monitoring several known immunologic abnormalities. Con A treated mice, in contrast to littermate controls, were found to have lower anti DNA levels, less proteinuria, a better response to primary sheep red cell immunization and normally rejected skin allografts.

Original languageEnglish (US)
Pages (from-to)220-224
Number of pages5
JournalInternational Archives of Allergy and Applied Immunology
Volume48
Issue number2
StatePublished - 1975
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Effect of concanavalin A on immunologic abnormalities of New Zealand (NZB/W) mice'. Together they form a unique fingerprint.

  • Cite this